Skip to product information

American Heart Association Scientific Sessions OnDemand 2022

American Heart Association Scientific Sessions OnDemand 2022

Regular price $20.00 USD
Regular price $20.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
American Heart Association Scientific Sessions OnDemand 2022

American Heart Association Scientific Sessions OnDemand 2022

Regular price $20.00
Regular price $20.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    American Heart Association Scientific Sessions OnDemand 2022

    + Include: 303 videos + 303 audios + 303 file sub vtt + 298 pdfs, size: 228 GB
    + Target Audience: cardiologists
    + Information:

    1. Overview

    The American Heart Association Scientific Sessions OnDemand 2022 is a premier global cardiovascular conference that highlights the latest scientific advancements, late-breaking clinical trials, and emerging therapies in cardiovascular medicine. The course covers a comprehensive array of topics including heart failure, interventional cardiology, prevention, and basic cardiovascular sciences to improve patient care and outcomes.

    Course Dates: November 5–7, 2022

    2. Learning Objectives

    • Evaluate the latest late-breaking clinical trials and their direct implications for cardiovascular disease management.

    • Implement updated American Heart Association guidelines for the prevention and treatment of various cardiovascular conditions.

    • Analyze new pharmacological and interventional therapies for heart failure, arrhythmias, and structural heart diseases.

    • Discuss the impact of health equity, digital health innovations, and novel technologies on cardiovascular care delivery.

    • Integrate basic and translational cardiovascular science findings into multidisciplinary clinical practice.

    3. Target Audience


    Best for cardiologists, researchers, and cardiovascular clinicians who want updates on late-breaking trials, heart failure, and AHA guidelines.

    4. Topics

      • 2022 State-of-the-Art Update on Salt and Hypertension   

      • 3CPR Shark Tank Session   

      • 3CPR Speed Mentoring   

      • 7 Questions About Cardiovascular Disease in Women 2022 Edition   

      • A Joint World Heart Federation (WHF) and AHA Session   

      • A Walk in the Park Turns Into a Fall in the Park_ The Underrecognized Problem of Falls Among Adults With CVD   

      • Achieving Equity in Diagnosis and Treatment of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy   

      • Acute Management of Arrhythmias in the Hospitalized Patient   

      • Adjunct Interventional Strategies for AF Management   

      • Advanced Imaging for Procedural Planning   

      • Advanced Technologies in Understanding Heart Failure   

      • Advancement in Cardiovascular Single Cell and Clonal Hematopoietic Biology   

      • Advances in Diabetes and Heart Failure_ From Bench to Bedside   

      • Advancing Health Equity and Inclusion in Lifestyle and Cardiometabolic Health Research   

      • AF Ablation for 2022 What’s New   

      • Age Friendly Care for the Older Adult With CVD and Stroke   

      • Aging and Cardiac Disease – Bench and Bedside Insights   

      • Ancel Keys Memorial Lecture   

      • Annual Update in Clinical Lipidology   

      • Are Social Determinants Permanent Going Beyond Observation to Intervention   

      • Arrhythmias and Heart Failure_ Breaking the Vicious Cycle   

      • At the Intersection of Intervention and Heart Failure   

      • Athero & Thrombo_ Reciprocal Regulation Between Lipids and the Hemostatic System   

      • Atrial Fibrillation and Cardioembolic Sources of Stroke a Continuous Challenge in Cerebral and Cardiovascular Disease   

      • Atrial Fibrillation_ What will be new in 2023 – AHA Joint Session with Heart Rhythm Society   

      • Battling It Out_ Controversies in Cardio-Renal Disease (Debates)   

      • Best in Science_ When AI Meets Cardiovascular Genomics   

      • Best Interventional Trials of 2022   

      • Best Practices and Guidelines for Cardiometabolic and Diabetes Care in 2022 A Flipped-Classroom Discussion With the Experts   

      • Beyond Statins_ Assessing and Addressing Residual Risk   

      • Beyond the Genetic Code_ The Role of Epigenetics in Pulmonary Hypertension   

      • Beyond the Heart_ Impact of CHD on Other Organ Systems Across the Lifespan   

      • Beyond the Pill_ Nonpharmacological Approaches in PAH   

      • Breaking the Mold for Carotid Imaging_ New Avenues in Diagnosis, Surveillance and Follow-Up   

      • Bridging Cardiology and Immunology   

      • Bridging the Chasm_ Gender, Racial and Socioeconomic Imbalances in Cardiovascular Disease   

      • Bringing Hope to Hopeless Cases   

      • Broad Perspectives in Metabolism   

      • Cardiac Arrhythmias in Patients With Kidney Disease- Finding the Right Rhythm   

      • Cardiac Myosin Inhibition, and its Role in the Landscape of Symptomatic NYHA Class II-III Obstructive HCM   

      • Cardiac Surgery and Atrial Fibrillation_ State of the Art   

      • Cardio-Nephrology as a Career Path What Does It Take   

      • Cardiovascular Disease in Diverse Immigrant Populations   

      • Cardiovascular Health for Cancer Survivors_ Advancing Preventive Cardio-Oncology   

      • Cardiovascular Medicine Relevant Updates in the Guidelines for the Prevention of Stroke in Patients With Stroke and TIA   

      • Cardiovascular Nano & Molecular Medicine_ Delivering on the Promise   

      • Career Transitions Success Stories from Two Academic Families   

      • Case-Based Session in Structural Heart Disease (TEER, TAVI, PFO)   

      • Challenges and Opportunities for Recruitment and Retention for Studies Involving Participant Enrollment   

      • Challenges and Solutions for Women and Underrepresented Persons Working in Hypertension Science   

      • Challenging Atrial Arrhythmias in the EP Lab A Case-Based Discussion   

      • Changing Views on Rhythm Control_ Is Earlier Better for Improving Outcomes in AF Patients_   

      • Charles T. Dotter Memorial Lecture   

      • Chronotherapy_ Non-Pharmacologic and Pharmacologic Interventions to Improve Circadian Blood Pressure   

      • Circulation Research_ 2022 Highlights and Initiatives   

      • Circulation_ Innovation in Cardiovascular Science and Medicine_ Part 1   

      • Circulation_ Innovation in Cardiovascular Science and Medicine_ Part 2  

      • Clinical and Surgical Management of End-Stage PAH   

      • Clinical Cardiovascular Genetics Boot Camp (Pre-Registration Required)   

      • Clinical Controversies and Technical Tips in Tavi_ A 2022 Perspective   

      • Clinical Debates in Cardiovascular Genetics   

      • Clinical Trials in Pulmonary Hypertension_ Novel Biomarkers and Endpoints   

      • Confronting the Epidemic of Amputations in Underserved Diabetic Populations   

      • Congenital Heart Research & Innovation 2022 and Beyond Power in Numbers Updates on CHD Clinical Trials and Multicenter Studies   

      • Consensus and Controversies_ Debating the 2021 ACC_AHA_SCAI Guidelines for Coronary Revascularization   

      • Contribution of Cardiovascular Disease to Brain Health and Cognition   

      • Controversies in Antithrombotic Therapy After Cerebrovascular Events   

      • Controversies in RV Dysfunction and Management_ A Pro-Con Debate   

      • Controversies in SAVR vs TAVR in European vs American Guidelines   

      • Controversies in the Cardiovascular Care of Young Athletes   

      • Conversations in Cholesterol Efflux_ How Can We Harness its Cardioprotective Potential_   

      • Cournand and Comroe Early Career Investigator Award Competition   

      • COVID-19 and the Pediatric Heart   

      • Critical Care Cardiology in Older Adults_ Too Little, Too Much, Too Late   

      • Cross-Specialty Approaches to Problems in Congenital Heart Disease and Pediatric Cardiology   

      • Crosstalk of Metabolic Pathways With Heart Failure Cell Signaling   

      • CRRT in the Cardiac Critical Care Setting_ An Overview for the Cardiologist   

      • CV Prevention at Every Opportunity_ Individual and Environmental Interventions   

      • CVRI Boot Camp (Pre-Registration Required)   

      • CVSA Early Career Investigator Abstract Award   

      • Developmental Pathways That Impact Cardiac Disease   

      • Dickinson W. Richards Memorial Lecture   

      • Did You Know Learn Novel Hypertension Research Discoveries   

      • Digital Health Equity Leveraging Informatics Interventions to Close the Gap in Health Outcomes for Patients with Cardiac Conditions   

      • Disparities in Multifactorial Cardiovascular Risk Reduction in Diabetes_ Know Diabetes by Heart and Beyond   

      • Doubly Disadvantaged_ Considerations for Cardiovascular Care Among Older Adults Across Gender and Racial Groups   

      • Dyspnea in Obesity_ When is It Heart Failure_   

      • Early Career CVSA – Pitfalls and Pearls   

      • Early Career EP   

      • Effect of Marijuana on Cardiovascular and Brain Health   

      • Elaine W. Raines Early Career Investigator Award Competition   

      • Elizabeth Barrett-Connor Research Award for Early Career Investigators in Training Competition   

      • EP Potpourri   

      • Evaluation of Renal Dysfunction and Shared Decision-Making of Advanced Cardio-Renal Therapies in Advanced Heart Failure   

      • Evolution of Critical Care Cardiology and the State-of-the-Art Contemporary Cardiac Intensive Care Unit   

      • Exerkines_ Mediators of Health and Disease   

      • Expanding Horizons in Vasculo-Oncology   

      • Expert Perspectives on the Management of Patients with CAD and_or PAD   

      • Fibroblasts and Fibrosis_ From Molecular Mechanisms to Actionable Targets   

      • Following Her Heart Across the Lifespan_ Cardiovascular Disease in Pregnancy & How Health Disparities Impact Maternal Mortality   

      • Forging Your Path – Building Careers in Cardio-Oncology   

      • Fostering the Future of Hispanic Health   

      • From Bench to Bedside_ A Potpourri of Novel Concepts in Cardio-Oncology   

      • From Deep Learning to Neural Networks_ The Use of Artificial Intelligence to Detect Cardiovascular Disease   

      • Frontiers in Science_ Arrhythmia Research Summit – Advances in Digital Health and Artificial Intelligence in Arrhythmia Management   

      • Frontiers in Science_ Arrhythmia Research Summit – Evaluation and Management of Syncope and Cardiac Dysautonomias_ A 2022 Update   

      • Frontiers in Science_ Arrhythmia Research Summit – Inherited Arrhythmias A 2022 Update   

      • Frontiers in Science_ Arrhythmia Research Summit – Novel Imaging Modalities from Bench to Bedside   

      • Frontiers in Science_ Arrhythmia Research Summit Bench to Bedside Translating New Players in Arrhythmogenesis   

      • Frontiers in Science_ Arrhythmia Research Summit Bench to Bedside_ Translating New Approaches to AF Ablation   

      • Frontiers in Science_ Atherosclerosis, Thrombosis and Vascular Biology Blood Clots in Infections – Were We Ready for COVID-19   

      • Frontiers in Science_ Atherosclerosis, Thrombosis and Vascular Biology_ The Battle of the Lipoproteins_ What Is Driving Residual   

      • Frontiers in Science_ Vascular Disease – Bringing Novel Devices to Patients   

      • Frontiers in Science_ Vascular Disease – Unmet Needs in Post-Thrombotic Syndrome_ Spotlight on Mechanisms, Outcomes and Therapies   

      • Genetic Therapies Are the Future of Treating Cardiomyopathy   

      • Genomic and Precision Medicine Early Career Investigator Award Competition   

      • George Lyman Duff Memorial Lecture   

      • GETTING TO THE HEART OF THE MATTER_ Management of CV risk in patients with CKD associated with T2D   

      • Great Debates in Cardiovascular Quality of Care   

      • Harmonizing US and European Blood Pressure Guidelines to Focus on Decreasing Global Cardiovascular Risk – AHA Joint Session   

      • Health Disparities Across The Heart Failure Disease Spectrum A Way Forward   

      • Health Technology Used to Effectively and Efficiently Run Real-World Efficacy Studies and Analysis   

      • Heart and Kidney Outcomes Trials_ A Deep Dive into Trial Design   

      • Heart-Neurons Interplay in Health and Disease   

      • Help Your MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI   

      • Hiding in Plain Sight_ Identification and Management of ATTR-CM Patients   

      • Highlighting the Achievements of Our ATVB Young Members   

      • Hot Debates in Heart Failure Diagnosis and Management   

      • Hot Topics in Acute Coronary Syndrome   

      • How can LEQVIO (inclisiran) help certain patients   

      • How to Perform Physiologic Pacing   

      • Hypertension Across the Lifespan in Women   

      • Identifying and Practicing Emerging Genomic Based Therapies on Cardiovascular Disease   

      • Imaging Wisely in Cardiac Amyloid_ How to Add Value in This New HFpEF Era   

      • Immuno-Oncological Therapies and Cardiovascular Health   

      • Implementable Guidelines and Health Technology to Effectively Operationalize Them   

      • Implementing Machine Learning for Precision Care_ Crossing the Bridge to Reality   

      • Improving Cardiovascular Disease Prevention in Latin America and the Caribbean Joint Session of the InterAmerican Heart Foundation   

      • Improving Cardiovascular Health Outcomes Through Real-World Science   

      • Improving Diversity in the Congenital Heart Disease Workforce   

      • In-depth and Fresh Look in Heart Failure Trials   

      • Inflammation and Cardiovascular Complications in Patients With Kidney Disease   

      • Inflammation and Metabolic Signals in Cardiometabolic Disease   

      • Inflammatory Mechanisms of Cardiac Disease   

      • Influence of Metabolism on Cardiac Function and Remodeling   

      • Inter- and Intragenerational Transmission of Cardiovascular Disease Risk_ Does Family Matter_   

      • Intersection of Kidney and Heart Failure – Biomarkers, Treatment and Outcomes in Patients With Cardiorenal Disease   

      • Interventional Central_ CHIP Deep Dive_ As Good as It Gets!   

      • Interventional Theater_ Case Presentation and Discussion Revascularization Guidelines to Practice   

      • Introduction to Single-Cell and Spatial Omics   

      • Is the Burden of Symptomatic Chronic HFrEF Inevitable_ Defining and recognizing early signs or symptoms of WHF   

      • Ischemic Heart Disease and ACS in Women_ The Usual and the Unusual   

      • Jardiance (empagliflozin) tablets A Review of the Latest Data   

      • Jay D. Coffman Early Career Investigator Award Competition   

      • Katharine Lembright Award and Lecture_Martha N. Hill New Investigator Award   

      • Kathleen A. Dracup Mentoring Award Lecture and Fireside Chat With Legends in Nursing   

      • Kenneth D. Bloch Memorial Lecture in Vascular Biology   

      • Kidney Dysfunction – Culprit in Heart Failure with Preserved Ejection Fraction_   

      • Laennec Clinician-Educator Award & Lecture   

      • Laennec Fellow In Training (Fit) Clinician Award Competition   

      • Late-Breaking Basic Science Oral Abstracts 1   

      • Late-Breaking Basic Science Oral Abstracts 2   

      • Late-Breaking Science_ Breakthrough Strategies in the HF Journey   

      • Late-Breaking Science_ The Main Event_ Changing Clinical Practice – Remote Presenter_ Daniel Levy   

      • Leveraging Health Technology to Support Smoking Cessation   

      • Life’s Essential 8_ AHA’s Enhanced Approach to Measuring, Monitoring and Modifying Cardiovascular Health   

      • Linkages Between Biomarkers and Patient-Reported Outcomes   

      • Lipids, Lipid Mediators and Lipoprotein Metabolism   

      • Living Your Best Life_ Targeting Equity in Palliative Care   

      • Louis N. and Arnold M. Katz Basic Science Research Prize for Early Career Investigators Competition   

      • Machine Learning, Biosensors, and Virtual Reality in CHD_ The Future Is Now   

      • Making the Learning Health System a Reality   

      • Managing Complex Procedures in Cardiovascular Medicine- AHA Joint Session with Israel Heart Society   

      • Marshalling the Promise of mHealth to Reduce Cardiovascular Disease Risk   

      • Mechanical Complications After Acute Myocardial Infarction_ What Do You Need to Know in 2022_   

      • Mechanism and Treatment of Lymphatic Diseases, Lipedema and Related Diseases   

      • Mechanisms of Right Ventricular Cardiomyopathy   

      • Meet the Expert in Cardiovascular Disease_ Basic Science   

      • Meet the Expert in Cardiovascular Disease_ Clinical Science   

      • Meet the Expert in Cardiovascular Disease_ Population Science   

      • Meet the Experts in Cardiogenic Shock   

      • Meet the Trialist_ EMPA-KIDNEY   

      • Meet the Trialist_ RAPID   

      • Melvin Judkins Early Career Clinical Investigator Award Competition   

      • Melvin L. Marcus Early Career Investigator Award in Cardiovascular Sciences Competition   

      • Mind the Gap_ Providing Optimal Cardiac Care for Patients in Life Transitions   

      • Mitral Valve Repairs and Replacements in 2022_ Open Surgical and Transcatheter Approaches   

      • Modern Cardio-Oncology_ From Mechanisms to Imaging   

      • Molecular Targets in Oncology Driving Cardiovascular Discovery and Therapy   

      • More Than Plaque Rupture_ Our Evolving Understanding of the Pathophysiology of ACS   

      • Moving the Needle on Global Hypertension Control Rates_ Putting Into Practice What We Know   

      • Multimodality Imaging in Chest Pain_ What, When and to Which Patients   

      • Myocardial Injury After Noncardiac Surgery   

      • Mythbusters_ What Do You Really Know About Complementary and Alternative Medicines in HF Management_   

      • Neurocardiology Pearls in Stroke Care_ Practical Management and Controversies   

      • Neurocardiology_ At the Intersection Between Cardiology and Stroke, an AHA-WSO Symposium   

      • New Advances in the Use of Polygenic Risk Scores in Clinical Practice   

      • New Contributors to Arrhythmia Mechanisms   

      • New Frontiers in Intracoronary Imaging and Physiology   

      • New Ideas in Cardiac Tissue Engineering   

      • New Insights Into Endothelial Dysfunction in Cardiovascular Disease   

      • Novel Aspects of Lipoprotein Composition and Function   

      • Novel Biomarker Utilization in Stable and Unstable CAD   

      • Novel Experimental Approaches for Arrhythmia Management and Risk Assessment   

      • Novel Insights in Hypertension Control and Management From Intervention Studies   

      • Novel Omics-Derived Insights Into the Pathogenesis of Pulmonary Arterial Hypertension   

      • Novel Regulation of Vascular Smooth Muscle Cell Function in Atherosclerosis   

      • Novel Therapeutics in Heart Failure   

      • Novel Tools for Clinical Decisions in Arrhythmic Disorders   

      • Observational and Clinical Trials in Nutrition   

      • Opening Session Moving Science into Public Health Lessons Learned Session Description US Surgeon Generals & International Public Health   

      • Overcoming Career Challenges Due to COVID-19   

      • Overcoming Challenges in Congenital Valve Disease   

      • Patient-Centered Models of Care_ How Are We Doing_   

      • Paul Dudley White International Lecture and Session_ Laurate, Storytelling and Perspectives for Syndemic and Global Cardiovascular   

      • Pecha Kucha Says It Is in the Genes   

      • Pediatric Obesity, the Next Frontier in Determinants of Health   

      • Percutaneous and Surgical Interventions for Ischemic and Structural Heart Disease in Heart Failure Patients Which has Superior Outcomes   

      • Peripheral Artery Disease – A Matter of Life and Limb   

      • Periprocedural Kidney Function Optimization_ A Converging Point for Nephrology and Interventional Cardiology   

      • Picture Worth a Thousand Words Image Guidance of Cardiac Valve Interventions   

      • Precision Health in Cardiovascular Nursing Science_ Prevention and Management of Cardiometabolic Health in Marginalized Populations   

      • Preclinical Testing of Bioengineered Cell and Tissue Therapies for Cardiovascular Diseases   

      • Pregnancy Complications and Cardiovascular Outcomes   

      • Pulmonary Vascular Emergencies in the CICU   

      • Quest Diagnostics and Steve Rusckowski Early Career Investigator Award for Preventive Cardiovascular Medicine Research   

      • Racial Disparities in Cardiovascular and Kidney Disease   

      • Rapid-Fire, Interdisciplinary, Actively-Moderated Case Discussions in Cardio-Metabolic Disorders   

      • Recent Advances in Device Therapy in Cardiac Disease- AHA Joint Session with Japanese Circulation Society   

      • Reconciling the Acute Chest Pain Guidelines Enabling AI Prediction of CV Risk   

      • Regenerative and Gene-Based Therapies for Pediatric Heart Disease   

      • Rethinking the Approach_ Management of Elevated LDL-C in Patients With ASCVD   

      • Rising to the Challenge of Aortic Disease in Pregnant Women   

      • Risk Stratification for Atherosclerotic CV Disease_ Utility of Risk Factors and Non-Invasive Testing   

      • Risk Stratification in Congenital Heart Disease and Pediatric Cardiology   

      • RNA Biology in Heart Failure   

      • Russell Ross Memorial Lectureship in Vascular Biology   

      • Samuel A. Levine Early Career Clinical Investigator Award Competition   

      • Seeing With a Functional Lens in Cardiovascular Research   

      • Shared Decision-Making_ Partnering to Improve Cardiovascular Health   

      • Sinus Tachycardia and POTS – Insights Into Mechanisms and Management   

      • Sol Sherry Distinguished Lecture in Thrombosis   

      • Solving the Heart Attack Crisis with Next Generation Plaque Analysis   

      • Special Focus on Lipoproteina From Biology to Therapy AHA Joint Session with American Society for Preventive Cardiology   

      • Special Topics in Fellow to Faculty Transition in Clinical Cardiology   

      • State of the Art Cardiovascular Care Atrial Fibrillation, Stroke and Heart Failure   

      • State of the Art Cardiovascular Care Primary Prevention of Cardiovascular Disease and Updates on COVID-19   

      • State of the Art Cardiovascular Care_ Updates in Interventional Structural Heart Disease   

      • State of the Art in Understanding the Genetics and Genomics of Cardiac Disease   

      • State of the Art Updates on the Management of CLTI   

      • State of the Art_ Cardiomyopathy   

      • State-of-the-Art Pulmonary Vascular Translational Science   

      • Stroke Risk From a Systemic Cardiovascular Perspective – New Scientific Developments   

      • Structural Case Theater – State of the Art Cases in Structural Interventions   

      • Successful Lifestyle Strategies and Novel Blood Pressure Measurement Technologies for Hypertension Control   

      • Surgical Therapy of Structural Heart Disease Oral Abstracts   

      • T. Duckett Jones Memorial Lecture and Outstanding Research Awards in Pediatric Cardiology   

      • Targeting LDL-C in ASCVD Patients_ Are We There Yet_   

      • Targeting Non-Coding RNAs for Cardiovascular Therapeutics   

      • Targeting the Mitochondria in the Ischemic Myocardium   

      • Team Science as an Early Career Investigator Teamwork Makes the Dream Work   

      • Technology and Health Care Delivery Innovation   

      • Temporary Mechanical Circulatory Support_ When, Why and How   

      • The ‘Epidemic of Epidemics’ – Intersectionality of Cardiometabolic Diseases and Social Inequalities from a Syndemic Perspective   

      • The 6th Link_ From Cardiac Arrest Survival to Developing Interventions for Optimal Survivorship   

      • The Cutting Edge of Thoracic Aortic Disease Management_ Updates and Controversies   

      • The ECG_ New Information From an Old Test   

      • The European Heart Journals Year in Cardiovascular Medicine Joint Symposium of the European Heart Journal   

      • The Evolving Landscape of Lipid Management   

      • The Great Debate_ Current Topics In Cardio-Oncology   

      • The Heart and the Kidney_ Why Can’t They Just Get Along_   

      • The Modern Vascular Clinic Practice_ Optimizing Pad Outcomes   

      • The Patient in Diabetes_ From Mechanism to Trials and on to Management   

      • The Right Intervention in the Right Patient at the Right Time_ Optimizing Outcomes in Cardiogenic Shock   

      • The Right Ventricle Carries the Load_ Right Ventricular Pathophysiology in Pulmonary Hypertension   

      • The Role of Antiarrhythmic Drugs in Early Rhythm Control and the Management of Atrial Fibrillation   

      • The Role of Omics in Vaccine Development_ Implications for Cardiovascular Health   

      • The Science of Cardiovascular Symptoms   

      • The Story of Goldilocks and the Three Advanced Heart Failure Patients Not Too Late, Not Too Early, the Just Right Time   

      • The Times They Are A-Changin_ Controversies in Anticoagulation for Venous Thromboembolism   

      • To Boldly Go! The Next Frontier in PE Clinical Trials   

      • Trained Immunity and Inflammation in Atherosclerosis   

      • Treating Recurrent Pericarditis and Preventing Recurrence   

      • Treatment Considerations for Patients with HFrEF and Select Updates From the 2022 HF Guideline   

      • Update on 2022 Cardiovascular Clinical Guidelines   

      • Update on HFpEF_ We Actually Have Treatments   

      • Utilizing Registries to Investigate Vascular Disease   

      • Vascular Complications of COVID_ Much Ado About Everything   

      • Vascular Smooth Muscle Cell Phenotypic Modulation in Vascular Disease and Aging   

      • Vasoplegia and Cardiac Surgery   

      • Ventricular Tachycardia Ablation_ What’s New for 2022_   

      • Visualizing COVID for the Long Haul_ Heart-Vasculature-Brain   

      • Vivien Thomas Early Career Investigator Award Competition   

      • Wearable Devices to Improve Cardiovascular Disease Outcomes   

      • Wearable Health Tech and the Impact of Future Practice Patterns   

      • Weaving Antiracism and Equity Into the Fabric of Cardiovascular Fellowship Training   

      • What’s New With Making New Hearts_   

      • Whats New in the Management of Uncontrolled Resistant Hypertension   

      • When to Follow Adult Guidelines in Pediatric Care and When to Diverge   

      • Who Is Behind the Wheel Drivers of Heart Failure Self-Care and Outcomes_   

      • William W.L. Glenn Lecture   

      • Young Hearts Early Career Investigator Competition   

      • Young Hearts Mentor & Mentee Panel Discussion Cultivating a Symbiotic Relationship